Literature DB >> 33471172

Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation.

Katja Evert1, Thomas Dienemann2, Christoph Brochhausen3, Dirk Lunz4, Matthias Lubnow5, Markus Ritzka2, Felix Keil3, Matthias Trummer3, Alexander Scheiter3, Bernd Salzberger6, Udo Reischl7, Peter Boor8, André Gessner7, Jonathan Jantsch7, Diego F Calvisi3, Matthias Evert3, Barbara Schmidt7, Michaela Simon7.   

Abstract

Between April and June 2020, i.e., during the first wave of pandemic coronavirus disease 2019 (COVID-19), 55 patients underwent long-term treatment in the intensive care unit at the University Hospital of Regensburg. Most of them were transferred from smaller hospitals, often due to the need for an extracorporeal membrane oxygenation system. Autopsy was performed in 8/17 COVID-19-proven patients after long-term treatment (mean: 33.6 days). Autopsy revealed that the typical pathological changes occurring during the early stages of the disease (e.g., thrombosis, endothelitis, capillaritis) are less prevalent at this stage, while severe diffuse alveolar damage and especially coinfection with different fungal species were the most conspicuous finding. In addition, signs of macrophage activation syndrome was detected in 7 of 8 patients. Thus, fungal infections were a leading cause of death in our cohort of severely ill patients and may alter clinical management of patients, particularly in long-term periods of treatment.
© 2021. The Author(s).

Entities:  

Keywords:  Autopsy; COVID-19; Fungal infection; Macrophage activation syndrome; Mycosis

Mesh:

Year:  2021        PMID: 33471172      PMCID: PMC7816067          DOI: 10.1007/s00428-020-03014-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission.

Authors:  A Oliva; G Ceccarelli; C Borrazzo; M Ridolfi; G D 'Ettorre; F Alessandri; F Ruberto; F Pugliese; G M Raponi; A Russo; A Falletta; C M Mastroianni; M Venditti
Journal:  Infection       Date:  2021-05-26       Impact factor: 3.553

Review 2.  COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion.

Authors:  Frank L van de Veerdonk; Roger J M Brüggemann; Shoko Vos; Gert De Hertogh; Joost Wauters; Monique H E Reijers; Mihai G Netea; Jeroen A Schouten; Paul E Verweij
Journal:  Lancet Respir Med       Date:  2021-05-26       Impact factor: 30.700

3.  Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.

Authors:  Danila Seidel; Michaela Simon; Rosanne Sprute; Matthias Lubnow; Katja Evert; Claudius Speer; Jessica Seeßle; Elham Khatamzas; Uta Merle; Christopher Behrens; Igor Wolfgang Blau; Philipp Enghard; Christian S Haas; Joerg Steinmann; Oliver Kurzai; Oliver A Cornely
Journal:  Mycoses       Date:  2021-11-16       Impact factor: 4.931

4.  Translational deep phenotyping of deaths related to the COVID-19 pandemic: protocol for a prospective observational autopsy study.

Authors:  Mikkel Jon Henningsen; Apameh Khatam-Lashgari; Kristine Boisen Olsen; Christina Jacobsen; Christian Beltoft Brøchner; Jytte Banner
Journal:  BMJ Open       Date:  2021-08-27       Impact factor: 2.692

5.  RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies.

Authors:  Tamara Caniego-Casas; Laura Martínez-García; Marina Alonso-Riaño; David Pizarro; Irene Carretero-Barrio; Nilda Martínez-de-Castro; Ignacio Ruz-Caracuel; Raúl de Pablo; Ana Saiz; Rosa Nieto Royo; Ana Santiago; Marta Rosas; José L Rodríguez-Peralto; Belén Pérez-Mies; Juan C Galán; José Palacios
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

6.  High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Authors:  Klaus Hirschbühl; Tina Schaller; Sebastian Dintner; Claudia Wylezich; Bruno Märkl; Rainer Claus; Eva Sipos; Lukas Rentschler; Andrea Maccagno; Bianca Grosser; Elisabeth Kling; Michael Neidig; Thomas Kröncke; Oliver Spring; Georg Braun; Hans Bösmüller; Maximilian Seidl; Irene Esposito; Jessica Pablik; Julia Hilsenbeck; Peter Boor; Martin Beer
Journal:  Mod Pathol       Date:  2022-04-01       Impact factor: 8.209

Review 7.  Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.

Authors:  Ruwandi M Kariyawasam; Tanis C Dingle; Brittany E Kula; Ben Vandermeer; Wendy I Sligl; Ilan S Schwartz
Journal:  Clin Microbiol Infect       Date:  2022-02-10       Impact factor: 13.310

Review 8.  Invasive mould disease in fatal COVID-19: a systematic review of autopsies.

Authors:  Brittany E Kula; Cornelius J Clancy; M Hong Nguyen; Ilan S Schwartz
Journal:  Lancet Microbe       Date:  2021-06-23

Review 9.  The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.

Authors:  Valeria Iliadi; Ina Konstantinidou; Konstantina Aftzoglou; Sergios Iliadis; Theocharis G Konstantinidis; Christina Tsigalou
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

10.  Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

Authors:  Paul E Verweij; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Jochem B Buil; Thierry Calandra; Tom Chiller; Cornelius J Clancy; Oliver A Cornely; Pieter Depuydt; Philipp Koehler; Katrien Lagrou; Dylan de Lange; Cornelia Lass-Flörl; Russell E Lewis; Olivier Lortholary; Peter-Wei Lun Liu; Johan Maertens; M Hong Nguyen; Thomas F Patterson; Bart J A Rijnders; Alejandro Rodriguez; Thomas R Rogers; Jeroen A Schouten; Joost Wauters; Frank L van de Veerdonk; Ignacio Martin-Loeches
Journal:  Intensive Care Med       Date:  2021-06-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.